CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	9 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Cash flows used in operating activities:
Net loss	$ (5,626,925)	$ (4,594,850)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	28,775	15,992
Stock based compensation	629,207	755,648
Loss on debt extinguishment	0	447,011
Gain on share for warrant exchanges	0	(51,190)
Accretion of right-of-use lease asset	(1,723)	862
Amortization of debt discount	0	30,287
Changes in operating assets and liabilities:
Accounts receivable	91,880	(206,729)
Prepaid expenses and other current assets	153,775	169,691
Accounts payable and other current liabilities	278,663	(271,533)
Deferred revenue	(100,000)	100,000
Due to related parties	20,039	27,558
Net cash used in operating activities	(4,526,309)	(3,577,253)
Cash flows from investing activities:
Purchases of property and equipment	(54,630)	(148,064)
Net cash used in investing activities	(54,630)	(148,064)
Net provided by (used in) financing activities
Proceeds from the issuance of common stock, net	7,260,869	4,987,468
Principal payments on convertible notes	0	(992,591)
Tax withholding payments or tax equivalent payments for net share settlement of restricted stock units and net stock option exercise	(106,391)	(38,981)
Net cash provided by financing activities	7,154,478	3,955,896
Net increase in cash and restricted cash	2,573,539	230,579
Cash and restricted cash at beginning of period	9,604,780	3,828,074
Cash and restricted cash at end of period	12,178,319	4,058,653
Supplement disclosures of cash flow information:
Interest	0	83,332
Supplemental information of non-cash investing and financing activities:
Initial recognition of right-of-use lease asset and lease liability	0	228,694
Par value of shares issued for round up following reverse stock split	0	4
Par value of shares issued for vested restricted stock units and net stock option exercise	$ 71	$ 10